骨盆底电刺激器市场、机会、成长动力、产业趋势分析与预测，2024-2032

全球骨盆底电刺激器市场估值为 2.441 亿美元，预计 2024 年至 2032 年复合年增长率为 11.4%。世界卫生组织强调，到 2030 年，全球每 6 个人就有 1 人年龄在 60 岁或以上。人口结构的转变，预计到 2020 年，老年人口将从 10 亿增加到 14 亿，这加剧了骨盆底疾病的盛行率。随着年龄的增长，他们的肌肉会减弱，组织弹性会降低，增加尿失禁的风险。因此，对为老年人量身定制的治疗解决方案的需求不断增加。

骨盆底电刺激器产业根据产品类型、应用、最终用途和地区进行细分。

在检查产品类型时，市场区分移动刺激器和固定刺激器。预测显示，到 2032 年，行动市场将飙升至 4.159 亿美元。这种创新的家庭医疗保健解决方案增强了可近性，特别是对于偏远地区的人们。此外，智慧型手机连接和个人化追踪等功能不仅能吸引用户，还能促进持续的参与。鑑于智慧型手机采用率的不断上升以及对非侵入性治疗的倾斜，该细分市场的成长轨迹似乎很陡峭。

骨盆底电刺激器的应用涵盖尿失禁、神经退化性疾病和性功能障碍。 2023年，尿失禁领域占据主导地位，估值为1.948亿美元。尿失禁盛行率激增，尤其是在老年人中，刺激了对有效非侵入性治疗的需求。患者倾向于保守治疗，加上医疗保健专业人员对骨盆底电刺激器的认可，进一步推动了他们的使用。意识的提高、诊断率的提高和技术创新也推动了市场的成长。

在美国，骨盆底电刺激器市场预计到 2032 年将达到 2.459 亿美元。城市研究所的数据强调了这一趋势，因为未来40 年，65 岁及以上的人口将增加一倍以上，到2040 年将达到惊人的8,000 万人。等疾病的盛行率也在增加。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 尿失禁盛行率增加
    • 提高认识倡议
    • 老年人口基数增加
    • 对非侵入性治疗方案的需求不断增长
  • 产业陷阱与挑战
    • 访问和分发有限
• 成长潜力分析
• 监管环境
• 技术景观
  • 核心技术
  • 邻近技术
• 未来市场趋势
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2021 - 2032

• 主要趋势
• 移动的
• 固定的

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 尿失禁
• 神经退化性疾病
• 性功能障碍

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 诊所
• 家庭护理设置
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Athena Feminine Technologies, Inc.
• Axena Health, Inc.
• Beacmed srl
• Chiaro Technology Limited
• Everyway Medical Instruments Co., Ltd.
• InControl Medical.
• Laborie
• Medtronic plc
• Nidd Valley Medical
• PeriCoach
• Shenzhen XFT Medical Limited
• TensCare Ltd
• The Prometheus Group
• Verity Medical Ltd
• Zynex, Inc.

The Global Pelvic Floor Electric Stimulator Market was valued at USD 244.1 million, with an estimated 11.4% CAGR from 2024 to 2032. A significant driver for this market is the rapidly aging global population. The WHO highlights that by 2030, one in every six individuals worldwide will be aged 60 years or older. This demographic transition, with the elderly population projected to swell from 1 billion in 2020 to 1.4 billion, is amplifying the prevalence of pelvic floor disorders. As individuals age, they face weakened muscles and reduced tissue elasticity, heightening the risk of urinary incontinence. Consequently, there is an escalating demand for therapeutic solutions tailored for the elderly.

The pelvic floor electric stimulator industry is segmented based on product type, application, end use , and region.

When examining product types, the market distinguishes between mobile and fixed stimulators. Projections suggest that the mobile segment will soar to USD 415.9 million by 2032. The allure of mobile stimulators lies in their convenience and portability, allowing users to seamlessly integrate pelvic floor exercises into their daily routines. This innovative home healthcare solution enhances accessibility, particularly for those in remote locales. Moreover, features like smartphone connectivity and personalized tracking not only captivate users but also promote consistent engagement. Given the rising smartphone adoption and a tilt towards non-invasive treatments, the segment's growth trajectory appears steep.

Applications of pelvic floor electric stimulators span urinary incontinence, neurodegenerative diseases, and sexual dysfunction. In 2023, the urinary incontinence segment dominated with a valuation of USD 194.8 million. The surging prevalence of urinary incontinence, notably among the elderly, has spurred demand for effective non-invasive treatments. The inclination of patients towards conservative therapies, coupled with healthcare professionals' endorsement of pelvic floor electric stimulators, has further fueled their uptake. The market growth is also buoyed by heightened awareness, better diagnosis rates, and technological innovations.

In the U.S., the pelvic floor electric stimulator market is on track to hit USD 245.9 million by 2032. The U.S. is witnessing a pronounced uptick in its aging demographic, a group more susceptible to pelvic floor disorders. Data from the Urban Institute underscores this trend as the population aged 65 and above is set to more than double in the next four decades, reaching a staggering 80 million by 2040. As this demographic expands, so does the prevalence of conditions like urinary incontinence and pelvic pain, driving the demand for solutions like pelvic floor electric stimulators.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in the prevalence of urinary incontinence
    • 3.2.1.2 Increasing awareness initiatives
    • 3.2.1.3 Rise in geriatric population base
    • 3.2.1.4 Growing demand for non-invasive treatment option
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Limited accessibility and distribution
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
  • 3.5.1 Core technologies
  • 3.5.2 Adjacent technologies
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Mobile
• 5.3 Fixed

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Urinary incontinence
• 6.3 Neurodegenerative diseases
• 6.4 Sexual dysfunction

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Home care settings
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Athena Feminine Technologies, Inc.
• 9.2 Axena Health, Inc.
• 9.3 Beacmed s.r.l.
• 9.4 Chiaro Technology Limited
• 9.5 Everyway Medical Instruments Co., Ltd.
• 9.6 InControl Medical.
• 9.7 Laborie
• 9.8 Medtronic plc
• 9.9 Nidd Valley Medical
• 9.10 PeriCoach
• 9.11 Shenzhen XFT Medical Limited
• 9.12 TensCare Ltd
• 9.13 The Prometheus Group
• 9.14 Verity Medical Ltd
• 9.15 Zynex, Inc.